Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Aug 17, 2020 at 12:12 PM EDT

XBiotech Has Identified COVID-19 Antibodies to Be Used as Therapy

XBiotech shares made a handy gain on Monday after the company said that it has identified True Human antibodies that…

Chris Lange | Aug 17, 2020 at 10:57 AM EDT

Unity Bio Stock Is Literally Kneecapped

Unity Biotechnology stock was absolutely crushed on Monday after the company announced results from its midstage study in patients with…

Chris Lange | Aug 17, 2020 at 10:28 AM EDT

What Sanofi Is Adding to Its Portfolio With This New Acquisition

Principia Biopharma shares jumped to start out the week after it was announced that it would be acquired by Sanofi.

Lee Jackson | Aug 15, 2020 at 6:35 AM EDT

5 Red-Hot Biotech and Medtech Stocks Under $10 With Massive Upside Potential

These are five biotech and medtech stocks for very aggressive accounts that look to get shares count leverage on companies…

Chris Lange | Aug 14, 2020 at 1:38 PM EDT

CureVac Enters the Market With a Bang

CureVac stock exploded into the market, more than double its original pricing. Since then, it is up more or less…

Chris Lange | Aug 14, 2020 at 11:27 AM EDT

Hydroxychloroqine Could Be Back in Play With Recent Taiwan FDA Filing

Taiwan Liposome Co. Ltd (NASDAQ: TLC) shares shot higher on Friday after the company announced it was making a regulatory…

Douglas A. McIntyre | Aug 14, 2020 at 6:23 AM EDT

As COVID-19 Spreads Across America, New York Still Has Most Deaths By Far

New York State may rank fourth in COVID-19 confirmed case count, but its death toll is well over twice that…

Douglas A. McIntyre | Aug 13, 2020 at 7:01 AM EDT

Over 500,000 US COVID-19 Deaths Forecast This Year

There are several academic models of how many Americans will die of COVID-19 this year. One puts the number at…

Chris Lange | Aug 12, 2020 at 11:28 AM EDT

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of…

Chris Lange | Aug 12, 2020 at 11:05 AM EDT

How Is Royalty Pharma Poised After Earnings?

Royalty Pharma reported quarterly results on Wednesday morning that were boosted by Imbruvica and the addition of new royalties.

Chris Lange | Aug 12, 2020 at 8:25 AM EDT

Short Sellers Shy Away From Big Biotech

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 11, 2020 at 10:43 AM EDT

Eyenovia Sees the Bigger Picture With New Licensing Deal

Eyenovia shares soared on Tuesday after the company announced an exclusive license agreement with Artic Vision.

Chris Lange | Aug 11, 2020 at 9:41 AM EDT

5 Speculative Biotechs With 50% to 300% Implied Upside

24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300%…

Chris Lange | Aug 10, 2020 at 10:09 AM EDT

Good News for C Diff Sufferers and Seres Therapeutics Investors

Seres Therapeutics shares more than tripled early on Monday after the firm announced positive late-stage results for its C. difficile…

Chris Lange | Aug 7, 2020 at 11:11 AM EDT

Investors Cheer AnPac Bio’s Coronavirus Developments

AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.

1 … 44 45 46 47 48 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

XBiotech Has Identified COVID-19 Antibodies to Be Used as Therapy

Unity Bio Stock Is Literally Kneecapped

What Sanofi Is Adding to Its Portfolio With This New Acquisition

5 Red-Hot Biotech and Medtech Stocks Under $10 With Massive Upside Potential

CureVac Enters the Market With a Bang

Hydroxychloroqine Could Be Back in Play With Recent Taiwan FDA Filing

As COVID-19 Spreads Across America, New York Still Has Most Deaths By Far

Over 500,000 US COVID-19 Deaths Forecast This Year

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

How Is Royalty Pharma Poised After Earnings?

Short Sellers Shy Away From Big Biotech

Eyenovia Sees the Bigger Picture With New Licensing Deal

5 Speculative Biotechs With 50% to 300% Implied Upside

Good News for C Diff Sufferers and Seres Therapeutics Investors

Investors Cheer AnPac Bio’s Coronavirus Developments

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

SLRC faces rate headwinds yet keeps dividend flat; here’s what’s propping up the stock

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

Health and Healthcare Articles

All Health and Healthcare Articles

XBiotech Has Identified COVID-19 Antibodies to Be Used as Therapy

Unity Bio Stock Is Literally Kneecapped

What Sanofi Is Adding to Its Portfolio With This New Acquisition

5 Red-Hot Biotech and Medtech Stocks Under $10 With Massive Upside Potential

CureVac Enters the Market With a Bang

Hydroxychloroqine Could Be Back in Play With Recent Taiwan FDA Filing

As COVID-19 Spreads Across America, New York Still Has Most Deaths By Far

Over 500,000 US COVID-19 Deaths Forecast This Year

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

How Is Royalty Pharma Poised After Earnings?

Short Sellers Shy Away From Big Biotech

Eyenovia Sees the Bigger Picture With New Licensing Deal

5 Speculative Biotechs With 50% to 300% Implied Upside

Good News for C Diff Sufferers and Seres Therapeutics Investors

Investors Cheer AnPac Bio’s Coronavirus Developments

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

SLRC faces rate headwinds yet keeps dividend flat; here’s what’s propping up the stock

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up